Objective:

To examine the prevalence of cognitive frailty and its associated factors among older patients with esophageal cancer undergoing chemotherapy, and to provide evidence for the development of targeted nursing interventions.

Approach:

Key Findings:

• The incidence of cognitive frailty among older patients with esophageal cancer undergoing chemotherapy was 45.1%.
• Significant factors associated with cognitive frailty included chemotherapy cycles, nutritional risk, sleep disturbances, depression, educational attainment, participation in cognitive training activities, and social support (p < 0.05).

Interpretation:

Cognitive frailty is relatively common among older patients undergoing chemotherapy for esophageal cancer and is influenced by multiple interrelated factors.

Limitations:

• The study used a convenience sample, which may limit generalizability.
• The cross-sectional design does not allow for causal inferences.

Conclusion:

Healthcare professionals should strengthen assessment and management during chemotherapy and develop targeted interventions to reduce the risk of cognitive frailty.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.